0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Viewpoint | 
Bruce M. Psaty, MD, PhD; Richard Platt, MD, MS; Russ B. Altman, MD, PhD
JAMA. 2015;313(15):1515-1516. doi:10.1001/jama.2015.1149.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2013;310(20):2140. doi:10.1001/jama.2013.283499.

News From the Centers for Disease Control and Prevention | 
JAMA. 2013;310(8):788. doi:10.1001/jama.2013.194564.

Global Health | 
M. J. Friedrich
JAMA. 2013;310(3):250. doi:10.1001/jama.2013.17116.

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2012;307(13):1357. doi:10.1001/jama.2012.372.

From the Centers for Disease Control and Prevention |  FREE
JAMA. 2012;307(1):29-31. doi:.

Commentary | 
Alberto Albanese, MD
JAMA. 2011;305(1):89-90. doi:10.1001/jama.2010.1937.

The World in Medicine | 
Joan Stephenson, PhD
JAMA. 2010;303(23):2346. doi:10.1001/jama.2010.798.

From the Centers for Disease Control and Prevention |  FREE
JAMA. 2010;303(21):2135. doi:.

Medical News & Perspectives | 
Bridget M. Kuehn
JAMA. 2009;302(16):1739-1741. doi:10.1001/jama.2009.1518.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Psychiatry
Original Investigation  | 
Shared Predisposition in the Association Between Cannabis Use and Subcortical Brain Structure
David Pagliaccio, PhD; Deanna M. Barch, PhD; Ryan Bogdan, PhD; et al.
JAMA Oncology
Invited Commentary  | 
JAK/STAT Pathway Inhibitors and Neurologic Toxicity Above All Else Do No Harm?
Bart L. Scott, MD; Pamela S. Becker, MD, PhD
JAMA Oncology
Original Investigation  | 
Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis A Randomized Clinical Trial
Animesh Pardanani, MD; Claire Harrison, MD; Jorge E. Cortes, MD; et al.
JAMA Facial Plastic Surgery
Invited Commentary  | 
Furthering the Understanding of Actions of Botulinum Toxin A
Catherine P. Winslow, MD